Manufacturers lobby US Congress for assistance to develop orphan products
This article was originally published in Clinica
Executive Summary
The US Medical Device Manufacturers Association (MDMA) last week called for legislation to speed up the development of medical devices for diagnosing and treating rare disorders. The concept is similar to the 1983 Orphan Drug Act that has successfully led to advances in pharmaceutical treatments for rare diseases.